Non‐interventional, prospective, observational study on spasticity‐associated symptom control with nabiximols as add‐on therapy in patients with multiple sclerosis spasticity in Austria

BACKGROUND AND PURPOSE: Randomized controlled trials and observational studies of nabiximols oromucosal spray in patients with multiple sclerosis (MS) spasticity have shown improvement in a range of associated symptoms (pain, spasms, fatigue, bladder dysfunction, and sleep disturbances). This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Guger, Michael, Hatschenberger, Robert, Leutmezer, Fritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097150/
https://www.ncbi.nlm.nih.gov/pubmed/36934456
http://dx.doi.org/10.1002/brb3.2947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097150/
https://www.ncbi.nlm.nih.gov/pubmed/36934456
http://dx.doi.org/10.1002/brb3.2947

Ejemplares similares